123 related articles for article (PubMed ID: 38444524)
1.
Hosoi H; Tabata S; Kosako H; Hori Y; Okamura T; Yamashita Y; Fujimoto K; Kajioka D; Suzuki K; Osato M; Yamada G; Sonoki T
Leuk Res Rep; 2024; 21():100451. PubMed ID: 38444524
[No Abstract] [Full Text] [Related]
2. Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.
Hosoi H; Niibori-Nambu A; Nah GSS; Bahirvani AG; Mok MMH; Sanda T; Kumar AP; Tenen DG; Ito Y; Sonoki T; Osato M
Gene; 2021 Mar; 774():145421. PubMed ID: 33444684
[TBL] [Abstract][Full Text] [Related]
3. IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
Xia ZN; Wang XY; Cai LC; Jian WG; Zhang C
FEBS Open Bio; 2021 Mar; 11(3):898-910. PubMed ID: 33449444
[TBL] [Abstract][Full Text] [Related]
4. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
5. Activation-induced deaminase expression defines mature B cell lymphoma in the mouse.
Gómez-Escolar C; Marina-Zárate E; Ramiro AR
Front Immunol; 2023; 14():1268930. PubMed ID: 37809061
[TBL] [Abstract][Full Text] [Related]
6. Selective Enhancer Dependencies in
Iyer AR; Gurumurthy A; Kodgule R; Aguilar AR; Saari T; Ramzan A; Rausch D; Gupta J; Hall CN; Runge JS; Weiss M; Rahmat M; Anyoha R; Fulco CP; Ghobrial IM; Engreitz J; Cieslik MP; Ryan RJH
bioRxiv; 2023 May; ():. PubMed ID: 37205448
[TBL] [Abstract][Full Text] [Related]
7. Branched-chain in situ hybridization for κ and λ light chains: A powerful ancillary technique for determining B-cell clonality in cytology samples.
Arora K; Chebib I; Zukerberg L; Gandhi M; Rivera M; Ting D; Deshpande V
Cancer Cytopathol; 2016 Mar; 124(3):203-12. PubMed ID: 26524200
[TBL] [Abstract][Full Text] [Related]
8. Two Pathways of p27
Sora RP; Ikeda M; Longnecker R
mBio; 2019 Apr; 10(2):. PubMed ID: 30992353
[TBL] [Abstract][Full Text] [Related]
9. Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation.
Stasevich EM; Uvarova AN; Murashko MM; Khabusheva ER; Sheetikov SA; Prassolov VS; Kuprash DV; Demin DE; Schwartz AM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563017
[TBL] [Abstract][Full Text] [Related]
10. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
11. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
[TBL] [Abstract][Full Text] [Related]
12. Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma.
Chen D; Zhao Z; Huang Z; Chen DC; Zhu XX; Wang YZ; Yan YW; Tang S; Madhavan S; Ni W; Huang ZP; Li W; Ji W; Shen H; Lin S; Jiang YZ
Bone Res; 2018; 6():11. PubMed ID: 29644114
[TBL] [Abstract][Full Text] [Related]
13. Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.
Tögel L; Nightingale R; Chueh AC; Jayachandran A; Tran H; Phesse T; Wu R; Sieber OM; Arango D; Dhillon AS; Dawson MA; Diez-Dacal B; Gahman TC; Filippakopoulos P; Shiau AK; Mariadason JM
Mol Cancer Ther; 2016 Jun; 15(6):1217-26. PubMed ID: 26983878
[TBL] [Abstract][Full Text] [Related]
14. 7-[[(4-methyl-2-pyridinyl)amino](2-pyridinyl)methyl]-8-quinolinol (compound 30666) inhibits enhancer activity and reduces B-cell lymphoma growth - A question of specificity.
Kasprzyk ME; Łosiewski W; Podralska M; Kazimierska M; Sura W; Dzikiewicz-Krawczyk A
Eur J Pharmacol; 2021 Nov; 910():174505. PubMed ID: 34534532
[TBL] [Abstract][Full Text] [Related]
15. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms.
Zingone A; Cultraro CM; Shin DM; Bean CM; Morse HC; Janz S; Kuehl WM
Leukemia; 2010 Jun; 24(6):1171-8. PubMed ID: 20393505
[TBL] [Abstract][Full Text] [Related]
17. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.
Aukema SM; Kreuz M; Kohler CW; Rosolowski M; Hasenclever D; Hummel M; Küppers R; Lenze D; Ott G; Pott C; Richter J; Rosenwald A; Szczepanowski M; Schwaenen C; Stein H; Trautmann H; Wessendorf S; Trümper L; Loeffler M; Spang R; Kluin PM; Klapper W; Siebert R;
Haematologica; 2014 Apr; 99(4):726-35. PubMed ID: 24179151
[TBL] [Abstract][Full Text] [Related]
18. Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis.
Li X; Duan Y; Hao Y
BMC Med Genomics; 2021 Mar; 14(1):69. PubMed ID: 33663517
[TBL] [Abstract][Full Text] [Related]
19. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
Strasser A; Harris AW; Bath ML; Cory S
Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.
Schmidt EV; Pattengale PK; Weir L; Leder P
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6047-51. PubMed ID: 3261863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
